Harbour Investments, Inc. Acadia Pharmaceuticals Inc Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $6,505 - $13,610	-500 Reduced 31.06%	1,110 $16,000
Q4 2021 Feb 16, 2022	SELL	$16.79 - $27.09 $3,358 - $5,418	-200 Reduced 11.05%	1,610 $38,000
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $4,970 - $7,802	-315 Reduced 14.82%	1,810 $30,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $39,285 - $55,525	2,025 Added 2025.0%	2,125 $52,000
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $2,502 - $5,499	100 New	100 $3,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.